Time & Date: 2 September, 11:00 – 12:00 CEST
Chairperson: N. Eter GERMANY
Speakers & Presentations:
N. Eter GERMANY
11:00 Introduction
A. Lee USA
11:02 Leveraging IRIS and big data to measure environmental risk factors for AMD
D. Barthelmes SWITZERLAND
11:10 12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry
N. Eter GERMANY
11:18 Anti-VEGF treatment obtained in the OREGIS registry
I. Westborg SWEDEN
11:26 RVO and DME treatment in the Swedish Macula register
R. Gale UK
11:34 Anti-VEGF vs Steroid vs laser for macular oedema secondary to retinal vein occlusion: Analysis of large UK real world evidence datasets
All Faculty
11:42 Discussion
